A 7-year surveillance of the drug resistance in Klebsiella pneumoniae from a primary health care center

Table 2 The antimicrobial drug resistance rates of Klebsiella pneumoniae from different resources

Antimicrobial drug	Blood, 300	Sputum, 3319	Genital secretion, 514	Urine, 495	P value
NIT	35.2	20.9	20.7	30.7	< 0.001
CZO	23.6	19.5	22.6	35.1	< 0.001
SAM	20.7	18	21.1	32.6	< 0.001
CRO	18.6	16.6	19.3	29.1	< 0.001
SXT	16	14	24	28.3	< 0.001
ATM	11.3	9.2	9.4	18.8	< 0.001
GEN	10.1	8.8	11.9	16.9	< 0.001
CAZ	9	6.5	5.9	14.2	< 0.001
LVX	7.6	3.6	4.7	14.8	< 0.001
CIP	6.1	5.3	8.4	14.5	< 0.001
FEP	5.5	4.2	1.8	10.7	< 0.001
TOB	3.2	3.3	2.7	8.8	< 0.001
TZP	3.2	2.5	0.2	4.7	< 0.001
IPM	2.9	2	0	3.6	< 0.001
AMK	2.3	1.7	0.2	4.7	< 0.001
CTT	1.7	2	0.2	4.3	< 0.001
ETP	0.9	1.5	0.2	2.7	< 0.001

NIT nitrofurantoin, CZO cefazolin, SAM sulbactam/ampicillin, CRO ceftriaxone, SXT sulfamethoxazole/trimethoprim, ATM aztreonam, GEN gentamycin, CAZ ceftazidime, LVX levofloxacin, CIP ciprofloxacin, FEP cefepime, TOB tobramycin, TZP piperacillin/tazobactam, IPM imipenem, AMK amikacin, CTT cefotetan, ETP ertapenem

ISSN: 1476-0711